PFF Webinar Library

ILD Day graphic

Progressive Pulmonary Fibrosis: What Patients Need to Know

Wed, Sep 14, 2022
Dr. Podolanczuk is a nationally and internationally recognized expert in interstitial lung disease. She received her undergraduate degree in Neuroscience from Brown University. She earned her MD from NYU School of Medicine. She completed residency in Internal Medicine and fellowship in Pulmonary and Critical Care Medicine at Columbia University. She received additional training in advanced pulmonary diseases at Columbia University. She also earned a Masters of Science in Patient-Oriented Research from Columbia’s Mailman School of Public Health, with a focus on epidemiology and biostatistics.
 
Dr. Podolanczuk is an NIH-funded investigator studying novel risk factors for pulmonary fibrosis in humans. Her research program focuses on understanding early or subclinical interstitial lung disease, characterizing imaging and blood biomarkers of pulmonary fibrosis, the role of environmental exposures, and the connection between cardiovascular disease and pulmonary fibrosis. She is also a site investigator for several multi-center clinical trials of new therapies for pulmonary fibrosis.

SPONSORED WITH THE GENEROUS SUPPORT OF

Boehringer-Ingelheim

Genentech_RGB2
 

Recent Webinars

  • Jul
    23
    2025

    Managing Pulmonary Hypertension and Interstitial Lung Disease: Symptoms, Tests, and Treatment

    View Webinar
  • Jun
    25
    2025

    Understanding Mold-Related Hypersensitivity Pneumonitis: Diagnosis, Treatment, and Remediation

    View Webinar
  • Jun
    04
    2025

    PFF Clinical Trial Innovation (CTI) Webinar Series June 2025

    View Webinar
  • May
    28
    2025

    Debunking Myths and Advancing Care for ILD related to Autoimmune Diseases | Virtual

    View Webinar